2022 NEI Congress Agenda
congress_home
faq_icon

Agenda


Academies and Workshops are independent programs from NEI Congress. Each requires a separate registration and fee.

Attendees can earn up to 21.25 CME/CE credits by attending all the sessions offered during Congress. Sessions will be held in Mountain Time (MT). The agenda is subject to change.


Wednesday, November 2



Child and Adolescent Psychiatry Academy

Broadmoor Hall

4.5 credits

12:00 pm - 1:00pm

Lunch Industry Symposium†: Addressing Unresolved Symptoms of Major Depressive Disorder (MDD): The Importance of Norepinephrine, Serotonin, and Dopamine Modulation

Sponsored by Otsuka America Pharmaceutical, Inc. and Lundbeck

— International Center



Michael Thase, MD

1:10 pm - 1:15 pm

Opening Remarks

1:15 pm - 2:15 pm

Adolescents and Substance Use Disorders: A Combustible Combination



Timothy E. Wilens, MD

2:15 pm - 3:15 pm

Assessment and Treatment of Pediatric Impulsive Aggression: A Transdiagnostic Issue



Adelaide S. Robb, MD

3:15 pm - 3:30 pm

Networking Break

3:30 pm - 4:30 pm

Identification and Treatment of the Self-Harming and Suicidal Adolescent



Nicole Ballinger, DO, MPH, FAPA

4:30 pm - 5:30 pm

Pediatric OCD: From Compulsion to Clomipramine



Jeffrey R. Strawn, MD

5:30 pm - 6:00 pm

Panel Q&A

Forensics Psychiatry Academy

Colorado Hall

4.5 credits

12:00 pm - 1:00pm

Lunch Industry Symposium†: Addressing Unresolved Symptoms of Major Depressive Disorder (MDD): The Importance of Norepinephrine, Serotonin, and Dopamine Modulation

Sponsored by Otsuka America Pharmaceutical, Inc. and Lundbeck

— International Center



Michael Thase, MD

1:10 pm - 1:15 pm

Opening Remarks

1:15 pm - 2:15 pm

Mental Health Diversion for Individuals With Schizophrenia



Katherine Warburton, DO

2:15 pm - 3:15 pm

The Most Secure and Intensive Treatment Setting: Cases, Lessons Learned, Questions Ahead



Carolina A. Klein, MD

3:15 pm - 3:30 pm

Networking Break

3:30 pm - 4:30 pm

Managing the Unique Challenges of Correctional Psychiatry



Charles L. Scott, MD

4:30 pm - 5:30 pm

The Antisocial Personality Spectrum: Diagnosis and Treatment



James L. Knoll, IV, MD

5:30 pm - 6:00 pm

Panel Q&A

6:00 pm - 8:00pm

Industry Scientific Poster Reception †

Sponsored by Sunovion and Otsuka Medical Affairs

— Estate House

Thursday, November 3



Pre-Conference Workshop: Precision Psychiatry

Broadmoor Hall

3.25 credits

7:00 am - 8:00 am

Breakfast Scientific Poster Session†

Sponsored by Supernus Pharmaceuticals, Inc.

— International Center



Vladimir Maletic, MD, MS

8:20 am - 8:30 am

Opening Remarks

8:30 am - 9:15 am

Blue Genes: Using Pharmacogenetics to Guide Prescribing



Jeffrey R. Strawn, MD

9:15 am - 10:00 am

Take Two Tablets and Call Me in the Morning: Prescription Digital Therapeutics



Andrew J. Cutler, MD

10:00 am - 10:15 am

Networking Break

10:15 am - 11:00 am

Pragmatic Precision Psychiatry: Utilizing Pharmacokinetics and Pharmacodynamics to Optimize Antipsychotic Treatment



Jonathan M. Meyer, MD

11:00 am - 11:45 am

Precision Mental Health: Using Biotypes to Personalize Treatment Selection for Mood Disorders



Manpreet K. Singh, MD, MS

11:45 am - 12:00 pm

Panel Q&A

NEI Congress

Broadmoor Hall

21.25 credits

12:15 pm - 1:15 pm

Lunch Industry Symposium†: Are You Talking With Your Adult Patients Living With Bipolar I Disorder About Maintenance Treatment with A Long-Acting Injectable (LAI)?

Sponsored by Otsuka America Pharmaceutical, Inc. and Lundbeck

— Colorado Hall



Todd Broder, MD and Laura Melaro, DNP, APRN, FNP-BC, PMHNP-BC




Lunch Industry Symposium †: A Case of Parkinson’s Disease Psychosis: Managing Hallucinations and Delusions Associated with Parkinson’s Disease Psychosis

Sponsored by Acadia Pharmaceuticals, Inc.

— International Center



Gustavo Alva, MD, DFAPA and Susan Scanland, MSN, CRNP, GNP-BC CDP

1:25 pm - 1:30 pm

Opening Remarks

1:30 pm - 2:30 pm

In the Red: Diagnosis and Treatment of Bipolar Mania



Roger S. McIntyre, MD, FRCPC

2:30 pm - 3:30 pm

Adding On: Utilizing Adjunctive Medications in the Treatment of Major Depressive Disorder



Thomas L. Schwartz, MD

3:30 pm - 4:30 pm

Exhibit Hall Networking Break

4:30 pm - 5:30 pm

Under the Covers: Update on the Diagnosis and Treatment of Insomnia



Andrew J. Cutler, MD and Jade Wu, PhD, DBSM

5:30 pm - 6:30 pm

Thank You, Next: Switching Antipsychotic Medications



Jonathan M. Meyer, MD

6:45 pm - 7:45 pm

Dinner Industry Symposium†: A Novel Nonstimulant Treatment Option for ADHD

Sponsored by Supernus Pharmaceuticals, Inc.

— International Center



Theresa R. Cerulli, MD and Gregory Mattingly, MD

Friday, November 4



7:00 am - 8:00 am

Breakfast Industry Symposium†: TAAR1: Science Behind a Potential New TAARget for Schizophrenia

— International Center



Craig Chepke, MD, FAPA, Vladimir Maletic, MD, MS and Gregory Mattingly, MD

8:10 am - 8:15 am

Opening Remarks

8:15 am - 9:15 am

Tipping the Scales: Overcoming Antipsychotic Side Effects to Improve Treatment Adherence



Roger S. McIntyre, MD, FRCPC

9:15 am - 10:15 am

All the Livelong Day: Optimizing Adult ADHD Treatment



Andrew J. Cutler, MD

10:15 am - 11:00 am

Exhibit Hall Networking Break

10:15 am - 11:00 am

Morning Industry Symposium†: The Biology of Depression: Shifting the Focus From Receptor Pharmacology to Neurocircuitry

— Bartolin Hall

Sponsored by Otsuka Pharmaceutical Development and Commercialization Inc



Madhukar H. Trivedi, MD

11:00 am - 12:00 am

Talk to Me: Patient Communication in Schizophrenia



Leslie Citrome, MD, MPH and Amber Hoberg, NP

12:15 pm - 1:15 pm

Lunch Industry Symposium†: The Management of Bipolar I Disorder

Sponsored by AbbVie

— International Center



Rakesh Jain, MD, MPH





Lunch Industry Symposium†: Clinical Considerations Regarding the Differential Diagnosis and Management of TD

Sponsored by Teva

— Colorado Hall



Richard Jackson, MD  

1:30 pm - 2:15 pm

Keep It Steady: Maintenance Treatment for Bipolar Disorders



Leslie Citrome, MD, MPH

2:15 pm - 3:00 pm

Don't Fall Asleep: Screening, Diagnosis, and Management of Narcolepsy and Idiopathic Hypersomnia



Thomas L. Schwartz, MD

3:00 pm - 4:30 pm

Exhibit Hall Networking Break / Scientific Poster Session

— Bartolin Hall

3:15 pm - 4:15 pm

Afternoon Industry Symposium†: Forging A New Path: Targeting Muscarinic Receptor Circuits in Schizophrenia

Sponsored by Karuna Therapeutics

— Bartolin Hall



Julie A. Carbray, PhD, PMHNP-BC, PM-HCNS-BC, APRN and Rakesh Jain, MD, MPH

4:30 pm - 5:30 pm

On the Blue End: Diagnosis and Treatment of Bipolar Depression



Manpreet K. Singh, MD, MS and Andrew J. Cutler, MD

5:30 pm - 6:30 pm

New Kids on the Block: Novel Receptor Science in the Treatment of Major Depressive Disorder



Andrew J. Cutler, MD

6:45 pm - 7:45 pm

Dinner Industry Symposium†: Making a Difference for Patients With Tardive Dyskinesia (TD) Proactively Recognizing and Treating an Overlooked Disorder

Sponsored by Teva Pharmaceuticals

— International Center



Richard Jackson, MD

Saturday, November 5



7:00 am - 8:00 am

Breakfast Industry Symposium†: Clinical Evidence Supporting the Use of a Once-Daily Atypical Antipsychotic for Bipolar Depression: Bipolar I or II

Sponsored by Intra-Cellular Therapies, Inc.

— International Center



Gregory W. Mattingly, MD

8:10 am - 8:15 am

Opening Remarks

8:15 am - 9:15 am

To the Moon and Back: Pediatric ADHD



Napoleon B. Higgins, Jr., MD

9:15 am - 10:15 am

Case-Based Differential Diagnosis of Movement Disorders



Laxman B. Bahroo, DO

10:15 am - 11:00 am

Exhibit Hall Networking Break

10:15 am - 11:00 am

Morning Industry Symposium†: Advancing the Understanding of the Biological Mechanisms of Depression

Sponsored by Sage Therapeutics, Inc. and Biogen Inc.

Bartolin Hall



Rakesh Jain, MD

11:00 am - 12:00 pm

Fast As You Can: Rapid-Acting Treatments for Depression



Kari L. Franson, PharmD, PhD, BCPP and Andrew J. Cutler, MD

12:00 pm - 1:30 pm

Exhibit Hall Networking Break

12:15 pm - 1:15 pm

Lunch Industry Symposium†: The Efficacy and Safety Profile of an Adjunctive Therapy for Adult Patients With Major Depressive Disorder (MDD)

Sponsored by Otsuka America Pharmaceutical, Inc. and Lundbeck

— International Center



Vladimir Maletic, MD, MS





Lunch Industry Symposium†: Rethink Treatment for Adults with Schizophrenia or Bipolar I Disorder

Sponsored by Alkermes

— Colorado Hall



Craig Chepke, MD

1:30 pm - 2:30 pm

Target Acquired? New Receptor Science in the Treatment of Schizophrenia



Stephen M. Stahl, MD, PhD, DSc (Hon.)

2:30 pm - 3:30 pm

Reasons to Hope: Evidence-Based Actions for Suicide Prevention



Christine Moutier, MD, and Stephen Stahl, MD, PhD, DSc (Hon.)

3:30 pm - 4:15 pm

Exhibit Hall Networking Break

3:30 pm - 4:30 pm

Afternoon Industry Symposium†: Agitation Associated with Alzheimer's Dementia (AAD): Clinical Presentation & Pathophysiology, Current Treatment & Unmet Need

Sponsored by Otsuka America Pharmaceutical, Inc. and Lundbeck

— Bartolin Hall



David Sultzer, MD

4:30 pm - 5:30 pm

Moving in the Right Direction: An Update on the Treatment of Tardive Dyskinesia



Laxman B. Bahroo, DO and Andrew J. Cutler, MD

5:30 pm - 6:30 pm

Early Use of LAI Antipsychotics for Patient Adherence, Relapse Prevention, and Brain Preservation



Leslie Citrome, MD, MPH and Andrew J. Cutler, MD

6:45 pm - 7:45 pm

Dinner Industry Symposium†: Coordination of Care Between Referring Psychiatrists and Treatment Center Provider

Sponsored by Janssen Pharmaceuticals

— International Center



Lisa Harding, MD and Vladimir Maletic, MD, MS

Sunday, November 6



7:00 am - 8:00 am

Breakfast Industry Symposium†: The Impact of Tardive Dyskinesia: The Data and a Patient Story

Sponsored by Neurocrine Biosciences, INC.

— International Center



Craig T.M. Chepke, MD  

8:10 am - 8:15 am

Opening Remarks

8:15 am - 9:00 am

No Woman, No Cry: Advancements in the Diagnosis and Treatment of Postpartum Depression



Mary C. Kimmel, MD

9:00 am - 10:00 am

When All Else Fails: Managing Treatment-Resistant Depression



William M. Sauvé, MD

10:00 am - 10:15 am

Networking Break

10:15 am - 11:15 am

A New Dawn? Recent Developments in Early Diagnosis and Treatment of Alzheimer's Disease



Danielle Goldfarb, MD

11:15 am - 11:45 am

Neuropsychiatric Symptoms in Alzheimer's Disease: Focus on Agitation



Stephen Stahl, MD, PhD, DSc (Hon.)

11:45 am - 12:30 pm

A Calming Presence: Managing Agitation in Bipolar Disorder and Schizophrenia



Leslie Citrome, MD, MPH

12:30 pm

Closing Remarks

12:30 pm - 1:30 pm

Lunch Industry Symposium†: Beyond the Monoamine Hypothesis: A Glutamatergic Approach to Treating Major Depressive Disorder

Sponsored by Axsome Therapeutics, Inc.

— International Center



†The content of all non-CME/CE events (Industry Symposia, Disease State Sessions, and Poster Sessions) and the views expressed therein are those of the presenting entity and not of NEI. They are not part of the scientific program and do not provide CME/CE credit. By attending a non-CME/CE event, the attendee opts in to receive follow-up information from the commercial sponsor.